Guggenheim Starts Merrimack Pharmaceuticals (MACK) at Buy

November 9, 2012 9:47 AM EST Send to a Friend
Get Alerts MACK Hot Sheet
Price: $9.76 +2.41%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 23
Trade MACK Now!
Join SI Premium – FREE
Guggenheim initiates coverage on Merrimack Pharmaceuticals (NASDAQ: MACK) with a Buy. PT $13.00.

For an analyst ratings summary and ratings history on Merrimack Pharmaceuticals click here. For more ratings news on Merrimack Pharmaceuticals click here.

Shares of Merrimack Pharmaceuticals closed at $6.84 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Add Your Comment